158 related articles for article (PubMed ID: 20103995)
1. Dosage escalation study of S-1 and irinotecan in metronomic chemotherapy against advanced colorectal cancer.
Ogata Y; Sasatomi T; Akagi Y; Ishibashi N; Mori S; Shirouzu K
Kurume Med J; 2009; 56(1-2):1-7. PubMed ID: 20103995
[TBL] [Abstract][Full Text] [Related]
2. Phase I/II study of S-1 combined with irinotecan for metastatic advanced gastric cancer.
Inokuchi M; Yamashita T; Yamada H; Kojima K; Ichikawa W; Nihei Z; Kawano T; Sugihara K
Br J Cancer; 2006 Apr; 94(8):1130-5. PubMed ID: 16570038
[TBL] [Abstract][Full Text] [Related]
3. Phase I study of S-1 combined with irinotecan (CPT-11) in patients with advanced gastric cancer (OGSG 0002).
Takiuchi H; Narahara H; Tsujinaka T; Gotoh M; Kawabe S; Katsu K; Iishi H; Tatsuta M; Fujitani K; Furukawa H; Taguchi T;
Jpn J Clin Oncol; 2005 Sep; 35(9):520-5. PubMed ID: 16141295
[TBL] [Abstract][Full Text] [Related]
4. A phase I/II study of oral uracil/tegafur (UFT), leucovorin and irinotecan in patients with advanced colorectal cancer.
Mackay HJ; Hill M; Twelves C; Glasspool R; Price T; Campbell S; Massey A; Macham MA; Uzzel M; Bailey SM; Martin C; Cunningham D
Ann Oncol; 2003 Aug; 14(8):1264-9. PubMed ID: 12881390
[TBL] [Abstract][Full Text] [Related]
5. Phase I/II study of a 3-week cycle of irinotecan and S-1 in patients with advanced colorectal cancer.
Kusaba H; Esaki T; Futami K; Tanaka S; Fujishima H; Mitsugi K; Sakai K; Ariyama H; Tanaka R; Kinugawa N; Ueki T; Mibu R; Baba E; Nakano S; Akashi K
Cancer Sci; 2010 Dec; 101(12):2591-5. PubMed ID: 21077997
[TBL] [Abstract][Full Text] [Related]
6. A phase I study of combination therapy with S-1 and irinotecan in patients with previously untreated metastatic or recurrent colorectal cancer.
Choi YH; Kim TW; Lee SS; Hong YS; Ryu MH; Lee JL; Chang HM; Kang YK
Cancer Chemother Pharmacol; 2011 Oct; 68(4):905-12. PubMed ID: 21290246
[TBL] [Abstract][Full Text] [Related]
7. Phase I clinical and pharmacokinetic/pharmacogenetic study of a triplet regimen of S-1/irinotecan/oxaliplatin in patients with metastatic colorectal or gastric cancer.
Park SR; Hong YS; Lim HS; Seong MW; Kong SY; Kim SY; Park YI; Jung KH
Cancer Chemother Pharmacol; 2013 Nov; 72(5):953-64. PubMed ID: 23982118
[TBL] [Abstract][Full Text] [Related]
8. [The current evidence of S-1 and irinotecan hydrochloride combination chemotherapy with tri-weekly schedule].
Goto A
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():125-30. PubMed ID: 16897987
[TBL] [Abstract][Full Text] [Related]
9. Phase I trial of neoadjuvant preoperative chemotherapy with S-1 and irinotecan plus radiation in patients with locally advanced rectal cancer.
Sato T; Kokuba Y; Koizumi W; Hayakawa K; Okayasu I; Watanabe M
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1442-7. PubMed ID: 17855009
[TBL] [Abstract][Full Text] [Related]
10. Phase I study of bevacizumab combined with irinotecan and S-1 as second-line chemotherapy in patients with advanced colorectal cancer.
Kusaba H; Esaki T; Kishimoto J; Uchino K; Arita S; Kumagai H; Mitsugi K; Akashi K; Baba E
Cancer Chemother Pharmacol; 2013 Jan; 71(1):29-34. PubMed ID: 23228984
[TBL] [Abstract][Full Text] [Related]
11. Phase II study of S-1 combined with irinotecan (CPT-11) in patients with advanced colorectal cancer.
Tsunoda A; Yasuda N; Nakao K; Narita K; Watanabe M; Matsui N; Kusano M
Oncology; 2009; 77(3-4):192-6. PubMed ID: 19729976
[TBL] [Abstract][Full Text] [Related]
12. Phase I trial of weekly irinotecan combined with UFT as second-line treatment for advanced colorectal cancer.
Alonso V; Escudero P; Zorrilla M; Isla MD; Herrero A; Mayordomo JI; Martinez-Trufero J; Sáenz A; Tres A; Antón A
Eur J Cancer; 2001 Dec; 37(18):2385-91. PubMed ID: 11720832
[TBL] [Abstract][Full Text] [Related]
13. Phase I/II study of sequential therapy with irinotecan and S-1 for metastatic colorectal cancer.
Yoshioka T; Kato S; Gamoh M; Chiba N; Suzuki T; Sakayori N; Kato S; Shibata H; Shimodaira H; Otsuka K; Kakudo Y; Takahashi S; Ishioka C
Br J Cancer; 2009 Dec; 101(12):1972-7. PubMed ID: 19920821
[TBL] [Abstract][Full Text] [Related]
14. Phase I study of daily S-1 combined with weekly irinotecan in patients with advanced non-small cell lung cancer.
Ishimoto O; Ishida T; Honda Y; Munakata M; Sugawara S
Int J Clin Oncol; 2009 Feb; 14(1):43-7. PubMed ID: 19225923
[TBL] [Abstract][Full Text] [Related]
15. Phase I study of S-1 combined with irinotecan (CPT-11) in patients with advanced colorectal cancer.
Tsunoda A; Yasuda N; Nakao K; Narita K; Yamazaki K; Watanabe M; Suzuki N; Kusano M
Oncology; 2007; 72(1-2):58-63. PubMed ID: 17998791
[TBL] [Abstract][Full Text] [Related]
16. A dose-finding study for oxaliplatin, irinotecan, and S-1 (OIS) in patients with metastatic or recurrent gastrointestinal cancer.
Han B; Jung JY; Kim HS; Cho JW; Kim KC; Lim H; Kang HS; Ha HI; Kim MJ; Kim JH; Choi DR; Jang G; Kim JH; Song H; Zang DY
Cancer Chemother Pharmacol; 2016 Nov; 78(5):949-958. PubMed ID: 27628195
[TBL] [Abstract][Full Text] [Related]
17. A multicenter phase I study of preoperative chemoradiotherapy with S-1 and irinotecan for locally advanced lower rectal cancer (SAMRAI-1).
Sato T; Hayakawa K; Tomita N; Noda M; Kamikonya N; Watanabe T; Kato D; Sakai Y; Hiraoka M; Shimada M; Ikushima H; Baba H; Oya N; Oya M; Nemoto-Murofushi K; Takeuchi M; Watanabe M
Radiother Oncol; 2016 Aug; 120(2):222-7. PubMed ID: 27317556
[TBL] [Abstract][Full Text] [Related]
18. Phase 1/2 clinical study of irinotecan and oral S-1 (IRIS) in patients with advanced gastric cancer.
Komatsu Y; Yuki S; Fuse N; Kato T; Miyagishima T; Kudo M; Kunieda Y; Tateyama M; Wakahama O; Meguro T; Sakata Y; Asaka M
Adv Ther; 2010 Jul; 27(7):483-92. PubMed ID: 20559897
[TBL] [Abstract][Full Text] [Related]
19. Phase I/II trial of irinotecan and S-1 combination chemotherapy as a second-line treatment for advanced colorectal cancer.
Takii Y; Yamazaki T; Okada T; Tani T; Funakoshi K; Maruyama S; Hasegawa J; Akazawa K; Hatakeyama K;
Chemotherapy; 2013; 59(5):338-43. PubMed ID: 24820531
[TBL] [Abstract][Full Text] [Related]
20. [Combination chemotherapy with S-1 plus CPT-11 for patients with advanced or recurrent colorectal cancer].
Tsunoda A; Nakao K; Kamiyama G; Narita K; Yamazaki K; Watanabe M; Suzuki N; Oonaka T; Kusano M
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():135-7. PubMed ID: 16897989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
